Investing In Early-Stage Oncology With Yosemite's Dan McHugh
About this episode
Dan McHugh discusses Yosemite's investment strategies in early-stage oncology and academic research funding.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Dan McHugh, head of the investment team at Yosemite, explains the San Francisco VC group's approach to investing in early-stage cancer therapeutics and funding academic research through unrestricted grants. Founded by Reed Jobs, son of Steve Jobs and Laurene Powell Jobs, Yosemite invests across drug modalities and supporting technologies in the oncology space. Dan talks about his path fr...
More episodes of Business Of Biotech
- Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
- The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
- Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.
- Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor
- Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash
- Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.
Explore listener stats, chart rankings, contacts and more on the Business Of Biotech podcast page.